FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

22350811000001104: Risedronate sodium 35mg tablets (Milpharm Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1608551000001118 Risedronate sodium 35mg tablets (Milpharm Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1608561000001115 Risedronate sodium 35mg tablets (Milpharm Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73669401000001110 Risedronate sodium 35mg tablets (Aurobindo Pharma Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
73669501000001114 Risedronate sodium 35mg tablets (Aurobindo Pharma Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risedronate sodium 35mg tablets (Milpharm Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Is a Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Has active ingredient Risedronate sodium false Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Has specific active ingredient Risedronate sodium true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has AMP True Risedronate sodium 35mg tablets (Milpharm Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start